Roche

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. 

CEO
Thomas Schinecker
CEOThomas Schinecker
Employees
112,774
Employees112,774
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1896
Founded1896
Employees
112,774
Employees112,774

RHHBY Key Statistics

Market cap
327.97B
Market cap327.97B
Price-Earnings ratio
21.14
Price-Earnings ratio21.14
Dividend yield
1.94%
Dividend yield1.94%
Average volume
1.84M
Average volume1.84M
High today
$51.05
High today$51.05
Low today
$50.31
Low today$50.31
Open price
$50.78
Open price$50.78
Volume
683.59K
Volume683.59K
52 Week high
$60.85
52 Week high$60.85
52 Week low
$37.51
52 Week low$37.51

RHHBY News

Barron's 12h
This Biotech Stock Is Up 11% on $2.3 Billion Roche Deal for Blood Cancer Drug

Biotech and Pharma This Biotech Stock Is Up 11% on $2.3 Billion Roche Deal for Blood Cancer Drug In this article NRIX RHHBY SPX Nurix Therapeutics landed a $2.3...

This Biotech Stock Is Up 11% on $2.3 Billion Roche Deal for Blood Cancer Drug
TipRanks 12h
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal

As previously reported, Wells Fargo downgraded Nurix Therapeutics (NRIX) to Equal Weight from Overweight with a price target of $25, down from $28. While the ec...

TipRanks 16h
Nurix Therapeutics Stock Soars 40% After $2.3B Blood Cancer Deal with Roche

Shares in biopharmaceutical company Nurix Therapeutics (NRIX) soared nearly 40% in pre-market trading after sealing a $2.3 billion blood cancer deal with Swiss...

Analyst ratings

50%

of 24 ratings
Buy
50%
Hold
41.7%
Sell
8.3%

More RHHBY News

Nasdaq 19h
Roche And Nurix Ink $2.3 Bln Collaboration To Co-Develop BTK Degrader Bexobrutideg

(RTTNews) - Roche (RHHBY) announced it has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics, Inc. (NRIX). The two compani...

Roche And Nurix Ink $2.3 Bln Collaboration To Co-Develop BTK Degrader Bexobrutideg
Simply Wall St 1d
How Oncology, Obesity and AI Diagnostics News At Roche Holding Has Changed Its Investment Story - simplywall.st

...

How Oncology, Obesity and AI Diagnostics News At Roche Holding Has Changed Its Investment Story - simplywall.st
TipRanks 4d
Roche reports developing PCR test for Ebola within six days

Roche (RHHBY) announced that it developed a Research Use Only molecular PCR test, via its subsidiary TIB MOLBIOL, for use on the LightCycler 480 I & II Systems,...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.